PCR e-Course 2020 Late-Breaking Trials - part 2

Summary

Watch a series of Late-Breaking Trials presented during the PCR e-Course 2020 and see how they might have an impact on your practice: 

  • 2-year safety of revascularisation deferral based on iFR or FFR
  • CABG and PCI in patients with CTO and multivessel disease
  • Routine revascularisation vs. medical therapy

Presentations available when logged in:

  • Two-year safety of revascularisation deferral based on iFR or FFR
  • CABG and PCI in patients with CTO and multivessel disease
  • Routine revascularisation vs. medical therapy: meta-analysis and review